Cancer Information Highlights, October 23, 2019

Cancer Information Highlights, October 23, 2019

Cancer Information Highlights From the National Cancer Institute Updating you about cancer causes, prevention, screening, treatment, coping, and more   New from NCI HPV Vaccine May Provide Men with “Herd Immunity” against Oral HPV Infections   Findings from a study that looked at the rate of oral HPV infections among vaccinated and unvaccinated adults aged 18–59 suggest that the HPV vaccine may be providing men with herd immunity against HPV infections. Learn more about the study and what the findings mean for preventing head and neck cancers. Virus Engineered to Kill Tumor Cells and Support Immune Cells   Read about a new study that suggests that viruses engineered to kill cancer cells, known as oncolytic viruses, can be further enhanced to improve the body’s immune response against tumors. Human Papillomavirus (HPV) Vaccines Learn about the most current recommendations for who should get the HPV vaccine on this updated page. Video—Advances in Liquid Biopsy Technology Scroll down this page to the video and watch as Dr. Shana Kelly explains what liquid biopsies are, how they can be used, and the future of this developing technology.   Also of Interest Choices for Care When Treatment May Not Be an Option There are options for people with advanced cancer. Learn more about palliative care, hospice care, and clinical trials. Immune Checkpoint Inhibitors Immune checkpoint inhibitors are a type of immunotherapy. Find out how they work against cancer, the types of cancer they treat, and the side effects they may cause